PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PHASQ

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	05 : 32	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2024/05/17	05 : 28	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/11/30	06 : 55	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/11/16	06 : 17	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/10/03	20 : 17	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/09/27	21 : 52	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/08/26	01 : 34	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/08/26	01 : 31	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/07/01	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/31	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/20	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/20	05 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/20	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/20	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/05/17	05 : 23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/04/04	05 : 06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/03/24	21 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/02/15	07 : 07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/02/15	05 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2023/02/15	04 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2022/12/23	22 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2022/12/21	20 : 10	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2022/12/03	06 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2022/11/16	06 : 21	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
2022/11/05	05 : 44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)